| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |